Your browser doesn't support javascript.
loading
Re: A low prostate-specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
Ning, Hao; Wu, Haihu; Lyu, Jiaju; Wu, Fei.
Affiliation
  • Ning H; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250014, P.R. China.
  • Wu H; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250014, P.R. China.
  • Lyu J; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250014, P.R. China.
  • Wu F; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250014, P.R. China. Electronic address: urowufei@gmail.com.
Eur J Cancer ; 187: 144-146, 2023 07.
Article in En | MEDLINE | ID: mdl-37163807
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur J Cancer Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur J Cancer Year: 2023 Document type: Article